The public comment period for the National Pain Strategy expires today (May 20th). “I think it’s a great step forward for researchers in the pain field and most importantly for patients with chronic pain,” said Dr. Seth Lederman, President and Chairman of Tonix Pharmaceuticals which is developing medicines for common disorders of the central nervous…

The National Pain Strategy – A Recipe for Parity?

The public comment period for the National Pain Strategy expires today (May 20th).

NIH deadline

Public comment period for the National Pain Strategy expires May 20th, 2015

“I think it’s a great step forward for researchers in the pain field and most importantly for patients with chronic pain,” said Dr. Seth Lederman, President and Chairman of Tonix Pharmaceuticals which is developing medicines for common disorders of the central nervous system including fibromyalgia.

“It addresses a huge need in our medical system and in the pain research structure,” he added. “Pain crosses across many disciplines and it’s important to have centralized group of people and resources focusing on it.”

Source Nationalpainreport.com
 

See also

Comments